Evidence map›Paper›PMID 33256153›Full record

ReviewMolecules (Basel, Switzerland)2020

Bhupendra Koul, Arvind Kumar, Dhananjay Yadav, Jun-O Jin

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Research progress onFrontiers in pharmacology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Skin-Whitening, Antiwrinkle, and Moisturizing Effects ofInternational journal of molecular sciences · 2025
    Article
  8. Antioxidant and Anti-Inflammatory Activities ofMolecules (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. An Update on Pharmacological and Phytochemical Aspects ofCurrent topics in medicinal chemistry · 2024
    Review
  13. Article
  14. Underlying Mechanisms ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Using of Essential Oils and Plant Extracts againstPlants (Basel, Switzerland) · 2022
    Article
  19. Clinical Potential of Himalayan HerbMolecules (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bhupendra KoulSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0002-8409-3624
Arvind KumarResearch Center for Chromatography and Mass Spectrometry, CROM-MASS, CIBIMOL-CENIVAM, Industrial University of Santander, Carrera 27, Calle 9, Edificio 45, Bucaramanga 680002, Colombia.
Dhananjay YadavDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0003-4047-7236
Jun-O JinDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0003-4216-8111

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medicine, TraditionalChemical PhenomenaEthnopharmacologyHumansPhytochemicalsPlant ExtractsPlants, MedicinalSaxifragaceaePhytochemicalsPlant Extractsanti-urolithiatic activityBergenia speciesbergeninbotanical descriptionpharmacologyphytochemistrytraditional uses

Identifiers

PMID33256153
PMCPMC7730924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.